English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
科伦博泰招股进行中 创新药浪潮下何以大放异彩?
Jun 30, 2023 10:33 HKT
科倫博泰招股進行中 創新藥浪潮下何以大放異彩?
Jun 30, 2023 10:32 HKT
Soligenix, Inc. CEO is Featured in an Interview with SmallCaps Daily
Jun 29, 2023 20:00 HKT
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
Jun 29, 2023 18:45 HKT
NanoViricides Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun
Jun 29, 2023 18:45 HKT
BioMed X Institute Starts Its First Research Project With Sanofi on Artificial Intelligence for Drug Development
Jun 29, 2023 17:00 HKT
四环医药:旗下轩竹生物创新药品安奈拉唑钠肠溶片获国家药监局批准上市
Jun 27, 2023 13:02 HKT
四環醫藥:旗下軒竹生物創新藥品安奈拉唑鈉腸溶片獲國家藥監局批准上市
Jun 27, 2023 13:01 HKT
Xuanzhu Biopharm, a subsidiary of Sihuan Pharmaceutical, Its Innovative Drug Anaprozole Sodium Enteric-coated Tablets Obtains Drug Registration Approval From NMPA
Jun 27, 2023 13:00 HKT
Prenetics与全球知名科学家卢煜明教授宣布成立2亿美元合资企业“Insighta” 推出突破性多种癌症早期筛查检测
Jun 26, 2023 09:39 HKT
Prenetics與全球知名科學家盧煜明教授宣布成立2億美元合資企業「Insighta」推出突破性多種癌症早期篩查檢測
Jun 26, 2023 09:38 HKT
Prenetics and Globally Renowned Scientist Prof. Dennis Lo Establish US$200m Joint Venture "Insighta" for Breakthrough Multi-Cancer Early Detection Screening
Jun 26, 2023 09:37 HKT
OKRA.ai, an Envision Pharma Group Company, Appoints Dr. Yahya Anvar to Senior Leadership Position
Jun 15, 2023 19:00 HKT
With an Eye on the Future, Biolog Launches Odin
Jun 15, 2023 17:09 HKT
沛嘉医疗TaurusTrio经导管主动脉瓣系统获批NMPA创新医疗器械绿色通道
Jun 14, 2023 10:51 HKT
沛嘉醫療TaurusTrio經導管主動脈瓣系統獲批NMPA創新醫療器械綠色通道
Jun 14, 2023 10:50 HKT
Proventus Bioscience Breaks Ground on Its New Production Facility and Expansion of Its Laboratories and Fermentation Plant
Jun 13, 2023 22:00 HKT
中国抗体SM17再增一项适应症研究申请 针对治疗特应性皮炎(AD)的新药研究申请获国家药监局药品审评中心受理
Jun 12, 2023 20:45 HKT
中國抗體SM17再增一項適應症研究申請 針對治療特應性皮炎(AD)的新藥研究申請獲國家藥監局藥品審評中心受理
Jun 12, 2023 20:44 HKT
SinoMab Submits another IND Application for SM17 for the Treatment of Atopic Dermatitis, Which was Accepted by NMPA CDE
Jun 12, 2023 20:43 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: